MP Bharat Agro's funding strategy shifts to potential equity dilution after ruling it out twice
The company previously said expansion would be funded via debt and internal accruals; now equity dilution is under discussion, an unexplained pivot.
What's new
- Q1 FY27 revenue ₹416 cr (up 1.6% YoY), EBITDA ₹66 cr (up 16% YoY).
- Dhule Phase 2 on track for Oct 2026; Phase 3 for Oct 2027.
- Capacity utilization low at 66-79% due to raw material disruptions.
- Management guided for at least 50% revenue increase in coming months.
Themes from the call
Demand
SSP sales grew 28% YoY and NPK sales grew 32% YoY despite industry production declines, indicating supply-constrained not demand-constrained market.
Margins
EBITDA margin improvement in Q1 came from low-cost inventory from Q4 FY26; that benefit is now exhausted, and raw material prices remain elevated.
Capital allocation
The funding strategy for Dhule Phase 2 and 3 has shifted from debt and internal accruals to potential equity dilution, creating uncertainty for existing shareholders.
Guidance watch
- At least 50% increase in turnover in coming months (directional, no precise target or timeframe).
- Existing plant utilization expected to reach ~90% from current 66-79%, contingent on raw material supply normalization.
- Dhule Phase 2 initial utilization estimated at 60% after Oct 2026 commissioning.
Risk flags
- Equity dilution risk now on the table after two prior denials, with no quantified amount or timeline.
- Low-cost inventory benefit exhausted; margin pressure likely as raw material costs remain elevated.
- Geopolitical uncertainty in West Asia persists, impacting freight and raw material availability.
- Capacity utilization ramp depends on monsoon demand and supply normalization, both uncertain.
Key quotes
-
"That plan is still under discussion and we can have pure equity infusion or debt plus equity infusion, debt plus internal accruals if it permits, but it is yet to be finalized."
— MD Pankaj Oswal, Jul 2026 call -
"For the coming three quarters... EBITDA we expect to maintain and revenue it will take a quantum jump."
— MD Pankaj Oswal, Jul 2026 call
The brief
MP Bharat Agro's Q1 numbers show resilient demand but weaker revenue growth, with margins buoyed by inventory timing that has now expired. The bigger news is the funding pivot. Twice last year management stated the Dhule expansion would be funded through debt and internal accruals, ruling out equity dilution. This quarter, that assurance is gone: the funding plan is 'still under discussion' and could include pure equity or a debt-equity mix. The shift is unexplained, and it arrives just as the company's low-cost inventory benefit fades and raw material costs stay high. Revenue guidance of at least 50% growth in coming months sounds ambitious given current capacity utilization of 66-79% and only 60% initial ramp expected from Dhule Phase 2. The October 2026 commissioning date for Phase 2 is maintained, but execution risk rises when the funding source is unclear. For a company that prided itself on self-funded expansion, the opening to equity dilution changes the investment case significantly.
MP Bharat Agro's expansion plan is ambitious, but its funding clarity is not – the equity dilution door is now open without a clear reason why.